<DOC>
	<DOC>NCT01198470</DOC>
	<brief_summary>The purpose of this investigation is to evaluate the safety and effectiveness of the TRIUMPHÂ® Lumbar Artificial Disc for the treatment of patients who are suffering from Degenerative Disc Disease (DDD) at one level from L1 to S1.</brief_summary>
	<brief_title>TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>Degenerative Disc Disease in one vertebral level between L1 and S1 Able to understand and sign informed consent Had at least 6 months of conservative treatment Oswestry Disability Index Score of at least 30 (one a 100 point scale) Other inclusion criteria as specified in approved IDE protocol Bilateral leg pain Back or leg pain of unknown etiology Prior fusion surgery or another spinal device implanted at any other lumbar level Osteoporosis or osteopenia Other exclusion criteria as specified in approved IDE protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Low back pain</keyword>
	<keyword>Leg pain</keyword>
	<keyword>Discogenic pain</keyword>
	<keyword>Degenerative Disc Disease (DDD)</keyword>
	<keyword>Herniated disc</keyword>
	<keyword>Radiculopathy</keyword>
</DOC>